These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11448894)

  • 1. The Cooperative Breast Cancer Tissue Resource: archival tissue for the investigation of tumor markers.
    Glass AG; Donis-Keller H; Mies C; Russo J; Zehnbauer B; Taube S; Aamodt R;
    Clin Cancer Res; 2001 Jul; 7(7):1843-9. PubMed ID: 11448894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transducer and activator of transcription-5 activation and breast cancer prognosis.
    Nevalainen MT; Xie J; Torhorst J; Bubendorf L; Haas P; Kononen J; Sauter G; Rui H
    J Clin Oncol; 2004 Jun; 22(11):2053-60. PubMed ID: 15169792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
    Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parafibromin expression in breast cancer: a novel marker for prognostication?
    Selvarajan S; Sii LH; Lee A; Yip G; Bay BH; Tan MH; Teh BT; Tan PH
    J Clin Pathol; 2008 Jan; 61(1):64-7. PubMed ID: 17468290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body weight correlates with mortality in early-stage breast cancer.
    Enger SM; Greif JM; Polikoff J; Press M
    Arch Surg; 2004 Sep; 139(9):954-58; discussion 958-60. PubMed ID: 15381612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Cripto and its prognostic significance in breast cancer: a study with long-term survival.
    Gong YP; Yarrow PM; Carmalt HL; Kwun SY; Kennedy CW; Lin BP; Xing PX; Gillett DJ
    Eur J Surg Oncol; 2007 May; 33(4):438-43. PubMed ID: 17125961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
    Voduc D; Nielsen TO; Cheang MC; Foulkes WD
    Hum Pathol; 2008 Oct; 39(10):1431-7. PubMed ID: 18620730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation of reproductive factors to mortality from breast cancer.
    Daling JR; Malone KE; Doody DR; Anderson BO; Porter PL
    Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):235-41. PubMed ID: 11895871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.
    Harbeck N; Nimmrich I; Hartmann A; Ross JS; Cufer T; Grützmann R; Kristiansen G; Paradiso A; Hartmann O; Margossian A; Martens J; Schwope I; Lukas A; Müller V; Milde-Langosch K; Nährig J; Foekens J; Maier S; Schmitt M; Lesche R
    J Clin Oncol; 2008 Nov; 26(31):5036-42. PubMed ID: 18711169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN
    Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-binding protein-3 in breast cancer: analysis with tissue microarray.
    Sheen-Chen SM; Zhang H; Huang CC; Tang RP
    Anticancer Res; 2009 Apr; 29(4):1131-5. PubMed ID: 19414355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of breast cancer using genetic algorithms and tissue microarrays.
    Dolled-Filhart M; Rydén L; Cregger M; Jirström K; Harigopal M; Camp RL; Rimm DL
    Clin Cancer Res; 2006 Nov; 12(21):6459-68. PubMed ID: 17085660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
    Salvucci O; Bouchard A; Baccarelli A; Deschênes J; Sauter G; Simon R; Bianchi R; Basik M
    Breast Cancer Res Treat; 2006 Jun; 97(3):275-83. PubMed ID: 16344916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
    J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
    Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic markers in node-negative breast cancer: a prospective study.
    Kute TE; Russell GB; Zbieranski N; Long R; Johnston S; Williams H; Stackhouse C; Wilkins L; Evans I; Berry P; Rimmer K; Tucker E
    Cytometry B Clin Cytom; 2004 May; 59(1):24-31. PubMed ID: 15108167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.
    Poremba C; Heine B; Diallo R; Heinecke A; Wai D; Schaefer KL; Braun Y; Schuck A; Lanvers C; Bànkfalvi A; Kneif S; Torhorst J; Zuber M; Köchli OR; Mross F; Dieterich H; Sauter G; Stein H; Fogt F; Boecker W
    J Pathol; 2002 Oct; 198(2):181-9. PubMed ID: 12237877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
    J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The concentration of tissue--type plasminogen activator (t-PA) in extracts of breast cancer tissue].
    Ziółkowska E; Pietrusińska E; Łozyńska-Podhrebelna D
    Pol Merkur Lekarski; 2008 Dec; 25(150):489-94. PubMed ID: 19205379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.
    Rudland PS; Platt-Higgins A; El-Tanani M; De Silva Rudland S; Barraclough R; Winstanley JH; Howitt R; West CR
    Cancer Res; 2002 Jun; 62(12):3417-27. PubMed ID: 12067984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.